FOXP3+CD4+ regulatory T cells (Tregs) are critical for immune homeostasis and respond to local tissue cues, which control their stability and function. We explored here whether developmental endothelial locus-1 (DEL-1), which, like Tregs, increases during resolution of inflammation, promotes Treg responses. DEL-1 enhanced Treg numbers and function at barrier sites (oral and lung mucosa). The underlying mechanism was dissected using mice lacking DEL-1 or expressing a point mutant thereof, or mice with T cell–specific deletion of the transcription factor RUNX1, identified by RNA sequencing analysis of the DEL-1–induced Treg transcriptome. Specifically, through interaction with αvβ3 integrin, DEL-1 promoted induction of RUNX1-dependent FOXP3 expression and conferred stability of FOXP3 expression upon Treg restimulation in the absence of exogenous TGF-β1. Consistently, DEL-1 enhanced the demethylation of the Treg-specific demethylated region (TSDR) in the mouse Foxp3 gene and the suppressive function of sorted induced Tregs. Similarly, DEL-1 increased RUNX1 and FOXP3 expression in human conventional T cells, promoting their conversion into induced Tregs with increased TSDR demethylation, enhanced stability, and suppressive activity. We thus uncovered a DEL-1/αvβ3/RUNX1 axis that promotes Treg responses at barrier sites and offers therapeutic options for modulating inflammatory/autoimmune disorders.
Xiaofei Li, Alessandra Colamatteo, Lydia Kalafati, Tetsuhiro Kajikawa, Hui Wang, Jong-Hyung Lim, Khalil Bdeir, Kyoung-Jin Chung, Xiang Yu, Clorinda Fusco, Antonio Porcellini, Salvatore De Simone, Giuseppe Matarese, Triantafyllos Chavakis, Veronica De Rosa, George Hajishengallis
Title and authors | Publication | Year |
---|---|---|
A novel IL-10 – DEL-1 axis promotes granulopoiesis and sepsis survival in early life
Eleni Vergadi, Ourania Kolliniati, Konstantina Lyroni, Eleftheria Ieronymaki, Ioanna Lapi, Vasileia–Ismini Alexaki, Eleni Diamantaki, Katerina Vaporidi, Eleftheria Hatzidaki, Helen Papadaki, Emmanouil Galanakis, George Hajishengallis, Triantafyllos Chavakis, Christos Tsatsanis |
Nature Communications | 2024 |
Identification of the biological functions and chemo-therapeutic responses of ITGB superfamily in ovarian cancer.
Han J, Lyu L |
Discover. Oncology | 2024 |
Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss
Wang H, Divaris K, Pan B, Li X, Lim JH, Saha G, Barovic M, Giannakou D, Korostoff JM, Bing Y, Sen S, Moss K, Wu D, Beck JD, Ballantyne CM, Natarajan P, North KE, Netea MG, Chavakis T, Hajishengallis G |
Cell | 2024 |
Developmental endothelial locus 1: the present and future of an endogenous factor in vessels
Jiang D, Yue H, Liang WT, Wu Z |
Frontiers in Physiology | 2024 |
Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by Porphyromonas gingivalis Lipopolysaccharide
Tamura H, Maekawa T, Domon H, Sirisereephap K, Isono T, Hirayama S, Hiyoshi T, Sasagawa K, Takizawa F, Maeda T, Terao Y, Tabeta K |
Pharmaceuticals | 2023 |
Inhibition of Integrin αvβ3-FAK-MAPK signaling constrains the invasion of T-ALL cells
Huang L, Zhu Y, Kong Q, Guan X, Lei X, Zhang L, Yang H, Yao X, Liang S, An X, Yu J |
Cell adhesion & migration | 2023 |
Immune Profiling Reveals Decreases in Circulating Regulatory and Exhausted T Cells in Human Hypertension
Alexander MR, Dale BL, Smart CD, Elijovich F, Wogsland CE, Lima SM, Irish JM, Madhur MS |
JACC: Basic to Translational Science | 2023 |
EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer.
Ke B, Liang ZK, Li B, Wang XJ, Liu N, Liang H, Zhang RP |
PeerJ | 2023 |
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade
Tabasum S, Thapa D, Giobbie-Hurder A, Weirather JL, Campisi M, Schol PJ, Li X, Li J, Yoon CH, Manos MP, Barbie DA, Hodi FS |
Cancer immunology research | 2023 |
Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation
Theresa Failer, Michael Amponsah-Offeh, Aleš Neuwirth, Ioannis Kourtzelis, Pallavi Subramanian, Peter Mirtschink, Mirko Peitzsch, Klaus Matschke, Sems M. Tugtekin, Tetsuhiro Kajikawa, Xiaofei Li, Anne Steglich, Florian Gembardt, Annika C. Wegner, Christian Hugo, George HAJISHENGALLIS, Triantafyllos Chavakis, Andreas Deussen, Vladimir Todorov, Irakli Kopaliani |
Journal of Clinical Investigation | 2022 |
Inflammation Resolution: Implications for Atherosclerosis
A Doran |
Circulation research | 2022 |
Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities
Li X, Wang H, Yu X, Saha G, Kalafati L, Ioannidis C, Mitroulis I, Netea MG, Chavakis T, Hajishengallis G |
Cell | 2022 |
Osteoimmunology in Periodontitis: Local Proteins and Compounds to Alleviate Periodontitis
Sirisereephap K, Maekawa T, Tamura H, Hiyoshi T, Domon H, Isono T, Terao Y, Maeda T, Tabeta K |
International journal of molecular sciences | 2022 |
Commentary on "Failer et al. (2022) Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation" J Clin Invest 2022 (https://doi.org/10.1172/JCI126155).
Sperandio M |
2022 | |
Mechanisms and Therapeutic Modulation of Neutrophil-Mediated Inflammation.
Hajishengallis G, Chavakis T |
Journal of dental research | 2022 |
Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
Zhao M, Zheng Z, Li C, Wan J, Wang M |
Frontiers in immunology | 2022 |
Targeting inflammation in hypertension
Deussen A, Kopaliani I |
Current Opinion in Nephrology and Hypertension | 2022 |
Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis
Hui Wang, Xiaofei Li, Tetsuhiro Kajikawa, Jieun Shin, Jong-Hyung Lim, Ioannis Kourtzelis, Kosuke Nagai, Jonathan Korostoff, Sylvia Grossklaus, Ronald Naumann, Triantafyllos Chavakis, George Hajishengallis |
Journal of Clinical Investigation | 2021 |
Mechanisms of exTreg induction
V Saxena, R Lakhan, J Iyyathurai, JS Bromberg |
European Journal of Immunology | 2021 |
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
G Hajishengallis, T Chavakis |
Nature Reviews Immunology | 2021 |
DEL-1: a potential therapeutic target in inflammatory and autoimmune disease?
G Hajishengallis, T Chavakis |
Expert Review of Clinical Immunology | 2021 |